首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of novel dendrimers having aspartate grafts and their ability to enhance the aqueous solubility of model drugs.
【24h】

Synthesis of novel dendrimers having aspartate grafts and their ability to enhance the aqueous solubility of model drugs.

机译:具有天冬氨酸接枝物的新型树状聚合物的合成及其增强模型药物的水溶性的能力。

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, a series of aspartate based dendrimers with different cores were synthesized in a convergent approach and well characterized by NMR and MS techniques. The aqueous solubility of the model drugs (L-Histidine, Naproxen, Methotrexate) was measured in the presence of this kind of dendrimers at room temperature in PBS buffers at pH 6, 7 and 8. Results clearly confirmed that the solubility enhancement was due to presence of dendrimers at different pH compared to their corresponding aqueous solubility at different pH. The results indicated that the aspartate based dendrimers could be considered as an effective supplement of PAMAM dendrimers in solubility enhancement and drug delivery. The surface groups played an important role in dendrimer-mediated solubility enhancement.
机译:在这项研究中,以收敛的方法合成了具有不同核心的一系列基于天冬氨酸的树枝状聚合物,并通过NMR和MS技术对其进行了很好的表征。在室温下,在pH分别为6、7和8的PBS缓冲液中,在存在这种树状聚合物的情况下,测量了模型药物(L-组氨酸,萘普生,甲氨蝶呤)的水溶解度。树枝状大分子在不同pH下的存在与其在不同pH下相应的水溶性相比结果表明,基于天冬氨酸的树枝状大分子可以被认为是PAMAM树枝状大分子在溶解度提高和药物递送方面的有效补充。表面基团在树枝状大分子介导的溶解度增强中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号